United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Students at IDEA Quest College Preparatory in Edinburg are honoring National Heart Month. The school is also honoring ...

Chemists at Emory University have invented a reaction to streamline the total synthesis of a compound, phaeocaulisin A, ...

The 80-year-old partnership between the federal government and research institutions has made the U.S. the leader in ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Germany's Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.

Insilico Medicine ( “Insilico”) , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today ...

Crown Laboratories, a portfolio company of Hildred Capital, has acquired Revance Therapeutics, a Nashville-based provider of dermal fillers. No financial terms were disclosed. Crown is a Johnson City, ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...